HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular characterization of a β-thalassemia intermedia patient presenting inferior vena cava thrombosis: interaction of the β-globin erythroid Krüppel-like factor binding site mutation with Hb E and α(+)-thalassemia.

Abstract
The molecular basis and hematological phenotype of adult Thai β-thalassemia intermedia (β-TI) patients encountered with inferior vena cava (IVC) thrombosis were investigated. Hematological and molecular analysis revealed a trait previously not described. The disease was caused by interaction of the β(+)-thalassemia (β(+)-thal) gene with the -90 (C > T) (HBB: c.-140C > T) transition within the erythroid Krüppel-like factor (EKLF) binding site of the β-globin gene promoter with Hb E (HBB: c.79G > A) and α(+)-thalassemia (α(+)-thal). Hematological data of the patient were compared with those of heterozygous forms of these defects found in his family members and different genotype-phenotype interactions are illustrated. Globin gene haplotype analysis indicates an independent origin of this Thai β(+)-thal gene. Accurate diagnoses as well as knowledge of genotype-phenotype relationships were required for providing appropriate management of such cases.
AuthorsThanet Prajantasen, Nattiya Teawtrakul, Goonnapa Fucharoen, Supan Fucharoen
JournalHemoglobin (Hemoglobin) Vol. 38 Issue 6 Pg. 451-3 ( 2014) ISSN: 1532-432X [Electronic] England
PMID25370867 (Publication Type: Case Reports, Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Kruppel-Like Transcription Factors
  • beta-Globins
  • erythroid Kruppel-like factor
  • Hemoglobin E
Topics
  • Adult
  • Budd-Chiari Syndrome (genetics, pathology)
  • Hemoglobin E (genetics)
  • Humans
  • Kruppel-Like Transcription Factors
  • Male
  • Mutation
  • Vena Cava, Inferior
  • alpha-Thalassemia (genetics, pathology)
  • beta-Globins (genetics)
  • beta-Thalassemia (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: